Association of putative functional variants in the PLAU gene and the PLAUR gene with myocardial infarction

Clinical Science

Volumn 119, Issue 8, 2010, Pages 353-359

  Xu, Jing ^a   Li, Wenlong ^a   Bao, Xunna ^b   Ding, Hu ^b   Chen, Jingzhou ^a   Zhang, Weili ^a   Sun, Kai ^a   Wang, Jizheng ^a   Wang, Xiaojian ^a   Wang, Hu ^a   Yu, Hui ^a   Song, Weihua ^a   Ma, Weiwei ^a   Zhang, Lin ^a   Wang, Changxin ^a   Wang, Daowen ^b   Hui, Rutai ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Gene variant; Myocardial infarction; Urokinase plasminogen activator (uPA); Urokinase plasminogen activator receptor (uPAR)

Indexed keywords

UROKINASE; UROKINASE RECEPTOR;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 77956369261     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100151     Document Type: Article

References (36)

1. Fischer, M., Broeckel, U., Holmer, S., Baessler, A., Hengstenberg, C., Mayer, B., Erdmann, J., Klein, G., Riegger, G., Jacob, H. J. et al. (2005) Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation 111, 855-862 (Pubitemid 40279886)
2. Marenberg, M. E., Risch, N., Berkman, L. F., Floderus, B. and de Faire, U. (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. N. Engl. J. Med. 330, 1041-1046
3. Binder, B. R., Mihaly, J. and Prager, G. W. (2007) uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view. Thromb. Haemostasis 97, 336-342
4. Chavakis, T., Kanse, S. M., May, A. E. and Preissner, K. T. (2002) Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation. Biochem. Soc. Trans. 30, 168-173
5. Padro, T., Emeis, J. J., Steins, M., Schmid, K. W. and Kienast, J. (1995) Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease. Arterioscler. Thromb. Vasc. Biol. 15, 893-902
6. Cozen, A. E., Moriwaki, H., Kremen, M., DeYoung, M. B., Dichek, H. L., Slezicki, K. I., Young, S. G., Veniant, M. and Dichek, D. A. (2004) Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death. Circulation 109, 2129-2135
7. -/- mice. Arterioscler. Thromb. Vasc. Biol. 29, 1737-1744
8. Krasnikova, T. L., Parfyonova, Y., Alekseeva, I. A., Arefieva, T. I., Mukhina, S. A., Dobrovolsky, A. B., Titaeva, Y., Lyakishev, A. A., Resink, T. J., Erne, P. et al. (1999) Urokinase plasminogen activator system in humans with stable coronary artery disease. Clin. Exp. Pharmacol. Physiol. 26, 354-357
9. Pawlak, K., Pawlak, D. and Mysliwiec, M. (2008) Urokinase-type plasminogen activator and metalloproteinase-2 are independently related to the carotid atherosclerosis in haemodialysis patients. Thromb. Res. 121, 543-548
10. Pawlak, K., Mysliwiec, M. and Pawlak, D. (2008) The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients. Thromb. Res. 122, 328-335
11. Raghunath, P. N., Tomaszewski, J. E., Brady, S. T., Caron, R. J., Okada, S. S. and Barnathan, E. S. (1995) Plasminogen activator system in human coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15, 1432-1443
12. Steins, M. B., Padro, T., Schwaenen, C., Ruiz, S., Mesters, R. M., Berdel, W. E. and Kienast, J. (2004) Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions. Blood Coagulation Fibrinolysis 15, 383-391 (Pubitemid 38901608)
13. May, A. E., Schmidt, R., Kanse, S. M., Chavakis, T., Stephens, R. W., Schomig, A., Preissner, K. T. and Neumann, F. J. (2002) Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction. Blood 100, 3611-3617 (Pubitemid 35303930)
14. Svensson, P. A., Hagg, D. A., Jernas, M., Englund, M. C., Hulten, L. M., Ohlsson, B. G., Hulthe, J., Wiklund, O., Carlsson, B., Fagerberg, B. et al. (2004) Identification of genes predominantly expressed in human macrophages. Atherosclerosis 177, 287-290 (Pubitemid 39505259)
15. Svensson, P. A., Olson, F. J., Hagg, D. A., Ryndel, M., Wiklund, O., Karlstrom, L., Hulthe, J., Carlsson, L. M. and Fagerberg, B. (2008) Urokinase-type plasminogen activator receptor is associated with macrophages and plaque rupture in symptomatic carotid atherosclerosis. Int. J. Mol. Med. 22, 459-464
16. Gu, J. M., Johns, A., Morser, J., Dole, W. P., Greaves, D. R. and Deng, G. G. (2005) Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice. J. Cell Physiol. 204, 73-82
17. Huang, C. M., Chen, C. L., Tsai, J. J., Tsai, C. H. and Tsai, F. J. (2004) Association between urokinase gene 3′-UTR T/C polymorphism and Chinese patients with rheumatoid arthritis in Taiwan. Clin. Exp. Rheumatol. 22, 219-222
18. Chou, H. T., Chen, Y. T., Wu, J. Y. and Tsai, F. J. (2004) Association between urokinase-plasminogen activator gene T4065C polymorphism and risk of mitral valve prolapse. Int. J. Cardiol. 96, 165-170
19. Tsai, F. J., Lin, C. C., Lu, H. F., Chen, H. Y. and Chen, W. C. (2002) Urokinase gene 3′-UTR T/C polymorphism is associated with urolithiasis. Urology 59, 458-461
20. Begin, P., Tremblay, K., Daley, D., Lemire, M., Claveau, S., Salesse, C., Kacel, S., Montpetit, A., Becker, A., Chan-Yeung, M. et al. (2007) Association of urokinase-type plasminogen activator with asthma and atopy. Am. J. Respir. Crit. Care Med. 175, 1109-1116
21. Ozturk, A., Minster, R. L., DeKosky, S. T. and Kamboh, M. I. (2007) Association of tagSNPs in the urokinase-plasminogen activator (PLAU) gene with Alzheimer's disease and associated quantitative traits. Am. J. Med. Genet. B Neuropsychiatry Genet. 144B, 79-82
22. Hansen, A. P., Petros, A. M., Meadows, R. P., Nettesheim, D. G., Mazar, A. P., Olejniczak, E. T., Xu, R. X., Pederson, T. M., Henkin, J. and Fesik, S. W. (1994) Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator. Biochemistry 33, 4847-4864
23. Yoshimoto, M., Ushiyama, Y., Sakai, M., Tamaki, S., Hara, H., Takahashi, K., Sawasaki, Y. and Hanada, K. (1996) Characterization of single chain urokinase-type plasminogen activator with a novel amino-acid substitution in the kringle structure. Biochim. Biophys. Acta 1293, 83-89
24. Finckh, U., van Hadeln, K., Muller-Thomsen, T., Alberici, A., Binetti, G., Hock, C., Nitsch, R. M., Stoppe, G., Reiss, J. and Gal, A. (2003) Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2. Neurogenetics 4, 213-217 (Pubitemid 37122223)
25. Riemenschneider, M., Konta, L., Friedrich, P., Schwarz, S., Taddei, K., Neff, F., Padovani, A., Kolsch, H., Laws, S. M., Klopp, N. et al. (2006) A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease. Hum. Mol. Genet. 15, 2446-2456
26. Przybylowska, K., Smolarczyk, K., Kulig, A., Romanowicz-Makowska, H., Dziki, A., Ulanska, J., Pander, B. and Blasiak, J. (2002) Antigen levels of the urokinase-type plasminogen activator and its gene polymorphisms in colorectal cancer. Cancer Lett. 181, 23-30 (Pubitemid 34310658)
27. Campbell, D. B., Li, C., Sutcliffe, J. S., Persico, A. M. and Levitt, P. (2008) Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res. 1, 159-168
28. Lee, Y. L., Chen, W., Chen, S. C., Cheng, W. E. and Shin, C. M. (2009) Polymorphisms in the genes of the urokinase plasminogen activation system in relation to non-small cell lung cancer. Am. J. Respir. Crit. Care Med. 179, A1095
29. Whitworth, J. A. (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J. Hypertens. 21, 1983-1992
30. Alberti, K. G. and Zimmet, P. Z. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med. 15, 539-553
31. Nanbu, R., Menoud, P. A. and Nagamine, Y. (1994) Multiple instability-regulating sites in the 3′ untranslated region of the urokinase-type plasminogen activator mRNA. Mol. Cell. Biol. 14, 4920-4928
32. Tran, H., Maurer, F. and Nagamine, Y. (2003) Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2. Mol. Cell. Biol. 23, 7177-7188
33. Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678
34. Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., Sigurdsson, A., Baker, A., Palsson, A., Masson, G. et al. (2007) A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316, 1491-1493 (Pubitemid 46906618)
35. Kathiresan, S., Voight, B. F., Purcell, S., Musunuru, K., Ardissino, D., Mannucci, P. M., Anand, S., Engert, J. C., Samani, N. J., Schunkert, H. et al. (2009) Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat. Genet. 41, 334-341
36. Samani, N. J., Erdmann, J., Hall, A. S., Hengstenberg, C., Mangino, M., Mayer, B., Dixon, R. J., Meitinger, T., Braund, P., Wichmann, H. E. et al. (2007) Genomewide association analysis of coronary artery disease. N. Engl. J. Med. 357, 443-453